Ligand validation:5WJ1

TP9: (3Z)-4-{[(4-AMINO-2-METHYLPYRIMIDIN-5-YL)METHYL]AMINO}-3-MERCAPTOPENT-3-EN-1-YL TRIHYDROGEN DIPHOSPHATE

TP9 is a Ligand Of Interest in 5WJ1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5WJ1_TP9_A_706	73%	12%	0.159	0.987	2.23	1.82	2	7	1	0	100%	1
5K2O_TP9_A_705	70%	15%	0.167	0.987	2.05	1.76	2	5	1	0	100%	1
5K3S_TP9_A_704	49%	14%	0.241	0.989	2.04	1.79	2	5	1	0	100%	1
7U1D_TP9_A_706	42%	10%	0.255	0.978	2.63	1.75	3	8	1	0	100%	0.89
6DEN_TP9_A_705	92%	21%	0.096	0.986	1.94	1.41	2	3	1	0	100%	0.9836
6DEM_TP9_A_704	89%	19%	0.107	0.987	2.08	1.43	3	3	1	0	100%	0.9824
6DER_TP9_A_706	87%	13%	0.112	0.985	2.15	1.82	2	6	0	0	100%	0.41
6DEO_TP9_A_704	87%	21%	0.112	0.983	1.94	1.38	3	3	2	0	100%	1
6DEQ_TP9_A_705	85%	13%	0.115	0.98	2.25	1.73	2	7	0	0	100%	0.9872

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.